Busulfan Suppliers & Bulk Manufacturers

Available Forms: Injection (IV), Oral Tablet

Available Strengths: Injection: 6 mg/mL; Tablet: 2 mg

Reference Brands: US: Busulfex® (IV), Myleran® (oral); EU: Busilvex® (IV), Myleran® (tablet)

Category: Oncology Cancer Care

Busulfan is available in Injection (IV), Oral Tablet and strengths such as Injection: 6 mg/mL; Tablet: 2 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Busulfan is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Busulfan can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Busulfan, available in 6 mg/mL IV injection and 2 mg oral tablets, is a critical alkylating agent used in conditioning regimens prior to hematopoietic stem cell transplantation (HSCT). Approved in both the US and EU under brands like Busulfex® and Busilvex®, it plays a key role in treating chronic myelogenous leukemia (CML) and other hematologic cancers. Manufactured under strict GMP conditions, Busulfan is supplied in sterile, ready-to-infuse formulations, making it ideal for oncology-focused B2B partnerships, licensing, and supply in regulated markets. Reliable sourcing of Busulfan is essential for transplant protocols in cancer care facilities.